LXXGF

Lexagene (QB) Stock Price

0.54
0.00 (0.0%)
0.54
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexagene Holdings Inc (QB) LXXGF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.54 06:58:04
Close Price Low Price High Price Open Price Previous Close
0.54
Bid Price Ask Price Spread News
0.0001 2.22 2.22 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.54 USD

Lexagene (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 53.16M 98.44M 77.80M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
279.04k $ - 0.00% - -

more financials information »

Lexagene (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LXXGF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.55460.5890.4780.5388952158,599-0.0146-2.63%
1 Month0.5220.620.4750.5372452228,7310.0183.45%
3 Months0.740.7470.4750.6259504335,347-0.20-27.03%
6 Months0.606650.9282450.4750.6518377322,901-0.06665-10.99%
1 Year0.38130.9282450.30380.59726279,9730.158741.62%
3 Years1.11461.280.30380.617108134,235-0.5746-51.55%
5 Years0.421.2850.30380.6401853125,7250.1228.57%

Lexagene (QB) Description

LexaGene is a biotechnology company commercializing the very first easy-to-use, fully automated, genetic analyzer that is open-access. The open-access feature empowers end-users to target any genetic sequence of interest, whether of pathogen or human origin. To take advantage of the open-access feature, end-users simply need to load their own real-time PCR assays onto the instrument to customize their tests or run validated assays the company is developing. LexaGene's analyzers offer excellent sensitivity, specificity, and breadth of pathogen detection while returning results in about 1 hour. The company expects to sell its technology in the food safety and veterinary diagnostics markets, as well as to markets that need easy-to-use customized testing such as biotechnology and pharmaceutical companies, academia, and institutions performing water quality monitoring, aquaculture pathogen surveillance, and others. LexaGene is listed as a Tier 2 company on the TSX Venture Exchange.


Your Recent History
USOTC
LXXGF
Lexagene (..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.